Pure Global

Intermittent Theta Burst Stimulation (iTBS) for Emotion Regulation in Bipolar Disorder - Trial NCT06274567

Access comprehensive clinical trial information for NCT06274567 through Pure Global AI's free database. This phase not specified trial is sponsored by Massachusetts General Hospital and is currently Not yet recruiting. The study focuses on Bipolar Disorder. Target enrollment is 136 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT06274567
Not yet recruiting
Device Trial
device
Trial Details
ClinicalTrials.gov โ€ข NCT06274567
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Intermittent Theta Burst Stimulation (iTBS) for Emotion Regulation in Bipolar Disorder
Targeting Emotion Regulation in Bipolar Disorder With Intermittent Theta Burst Stimulation: A Mechanistic Study

Study Focus

Bipolar Disorder

Transcranial Magnetic Stimulation (TMS)

Interventional

device

Sponsor & Location

Massachusetts General Hospital

Charlestown, United States of America

Timeline & Enrollment

N/A

Apr 01, 2024

Mar 31, 2029

136 participants

Primary Outcome

Correlated functional magnetic resonance imaging (fMRI) time series (functional connectivity)

Summary

The objective of this study protocol is to test whether intermittent theta-burst transcranial
 magnetic stimulation (iTBS-TMS) to the inferior parietal lobule (IPL) can strengthen
 functional connectivity with a key region in emotion regulation (ER) neurocircuitry (anterior
 insula, AI) and improve performance on ER-related tasks in patients with bipolar disorder.
 Individual IPL sites for stimulation will be identified through baseline, pre-TMS functional
 magnetic resonance imaging (fMRI) scans. Patient-specific IPL subregions showing positive
 functional connectivity with the anterior insula and falling within the patient-specific
 frontoparietal control network will be used as individualized target sites for TMS
 stimulation. Patients will be randomized to receive 24 sessions of active versus sham iTBS to
 patient-specific IPL targets (6 sessions/day, 4 days, 43,200 pulses total). Post-iTBS
 resting-state and task-based fMRI scans will be acquired 3 days after the final day of iTBS
 administration (Day 4) following identical procedures as baseline. Effects of iTBS-TMS on ER
 will be evaluated by comparing pre-TMS versus post-TMS functional connectivity and behavior
 during performance on ER tasks.

ICD-10 Classifications

Bipolar affective disorder
Bipolar affective disorder, unspecified
Other bipolar affective disorders
Bipolar affective disorder, currently in remission
Bipolar affective disorder, current episode mixed

Data Source

ClinicalTrials.gov

NCT06274567

Device Trial